Tetra Pharm opens new headquarters to boost cannabinoid drug research and manufacturing

Dan­ish biotech Tetra Pharm Tech­nolo­gies has com­plet­ed the con­struc­tion of a new fa­cil­i­ty in Scan­di­navia so it can push through with its long-term growth plans.

The 43,000-square-foot plant is in Medicon Val­ley, sit­u­at­ed in the Greater Copen­hagen re­gion and South­ern Swe­den. The build­ing it­self was pre­vi­ous­ly a man­u­fac­tur­ing fa­cil­i­ty for med­ical de­vice firm Am­bu.

Copen­hagen-based Tetra Pharm is look­ing to boost its R&D, specif­i­cal­ly on cannabi­noid-based drugs for neu­ro­path­ic pain, scle­ro­sis and men­tal health dis­or­ders. The site will al­so help it in­crease its man­u­fac­tur­ing and pro­duc­tion ca­pac­i­ty, Tetra Pharm said in a press re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.